Safety and Feasibility Study of the MitraFix® Transcatheter Mitral Valve System
NCT: NCT07501234 · RECRUITING
Brief Summary
The goal of this early feasibility clinical trial is to test a new device called the MitraFix® Transcatheter Mitral Valve System. It aims to learn if the device is safe and if it can help adults who have a severe leaky heart valve (mitral regurgitation). This study is for people who are at high risk for traditional open-heart surgery. The main questions it aims to answer are: Is the MitraFix system safe for participants? Can the device be successfully placed in the heart? Does the device help reduce the valve leak and improve daily life? Participants will: Receive the MitraFix valve through a small tube inserted into a vein in the leg. Visit the clinic for heart tests, walking tests, and health checks for up to one year after the procedure.
Frequently Asked Questions
What is Safety and Feasibility Study of the MitraFix® Transcatheter Mitral Valve System?
Safety and Feasibility Study of the MitraFix® Transcatheter Mitral Valve System is a clinical trial registered under NCT07501234. Current status: RECRUITING.
What is the status of NCT07501234?
The current status of NCT07501234 (Safety and Feasibility Study of the MitraFix® Transcatheter Mitral Valve System) is: RECRUITING.
When did Safety and Feasibility Study of the MitraFix® Transcatheter Mitral Valve System start?
Safety and Feasibility Study of the MitraFix® Transcatheter Mitral Valve System started on 2026-03-23.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.